StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Let's play the how many tests per day quiz

<< Previous

Bullboard Posts

Next >>

Comment by davewhoon Feb 24, 2021 9:18am

102 Views

Post# 32645374

RE:RE:RE:RE:RE:RE:Let's play the how many tests per day quiz

James said quite some time ago that SZLS would not do tests for the sake of just adding test numbers. They learned a hard lesson about doing tests and then not getting paid for them. I think many other small companies have yet to learn that lesson. Its one thing for a company to say we are doing 1000 tests a day but then they have no rev in the QR's to report. We had record rev in Q3 and James has said that will increase in Q4 and Q1. Likely all of 2021 the way covid19 is hanging around.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario